0001140361-17-021016.txt : 20170516
0001140361-17-021016.hdr.sgml : 20170516
20170516165743
ACCESSION NUMBER: 0001140361-17-021016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170512
FILED AS OF DATE: 20170516
DATE AS OF CHANGE: 20170516
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytomX Therapeutics, Inc.
CENTRAL INDEX KEY: 0001501989
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273521219
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650.515.3185
MAIL ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goeltz II Robert C.
CENTRAL INDEX KEY: 0001653881
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37587
FILM NUMBER: 17849353
MAIL ADDRESS:
STREET 1: 343 OYSTER POINT BLVD
STREET 2: SUITE 100
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc1.xml
FORM 4
X0306
4
2017-05-12
1
0001501989
CytomX Therapeutics, Inc.
CTMX
0001653881
Goeltz II Robert C.
151 OYSTER POINT BLVD
SUITE 400
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Financial Officer
Common Stock
2017-05-12
4
M
0
9980
4.4728
A
22769
D
Common Stock
2017-05-12
4
M
0
9987
6.6147
A
32756
D
Stock Option (Right to Buy)
4.4728
2017-05-12
4
M
0
9980
0.00
D
2025-05-06
Common Stock
9980
204678
D
Stock Option (Right to Buy)
6.6147
2017-05-12
4
M
0
9987
0.00
D
2025-08-25
Common Stock
9987
85891
D
This option vests 25% on May 4, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on May 4, 2019.
This option vests in 48 substantially equal monthly installments starting on August 28, 2015, with each additional installment vesting on the last day of the month starting in September 2015.
/s/ Cynthia J. Ladd, as Attorney-in-Fact for Robert C. Goeltz II
2017-05-16